Vir Biotechnology, Inc. (VIR)

Healthcare · Biotechnology · NASDAQ

Vir Biotechnology, Inc. (VIR) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.95B and a free-cash-flow yield of -24.9%. Over the most recent reported fiscal year, revenue grew 4.4%.

Market cap	$1.95B
Trailing P/E	—
FCF yield	-24.9%
Revenue growth (YoY)	+4.4%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live VIR data on Nama Insights →